Theseus Pharmaceuticals
Developing best-in-class kinase inhibitors to shape the future of targeted oncology. Learn more
Launch date
Employees
Market cap
AUD280m
Enterprise valuation
(AUD31m) (Public information from Feb 2024)
Share price
$4.06 THRX
Cambridge Massachusetts (HQ)
Authorizing premium user...